Anna Stepanenko

Back to Jobs

Anna Stepanenko joined Otonomy in March 2014 and has assumed increasing responsibility leading to her appointment as Vice President, Technical Operations in January 2020. Ms. Stepanenko has over 20 years of product development and CMC experience supporting pharmaceutical products from Phase I through commercialization. Ms. Stepanenko has broad expertise in pre-formulation development as well as in manufacturing, process development, scale-up and process validation for drug substances and drug products. Prior to Otonomy, she served as the Director, Technical Operations at Optimer Pharmaceuticals where she was responsible for GMP manufacturing from clinical development through commercialization. Prior to Optimer, she held various formulation science, process development and pharmaceutical manufacturing positions at Prometheus Laboratories, Neurocrine Biosciences, Magellan Laboratories, and Amylin Pharmaceuticals. Ms. Stepanenko received her Master’s degree in Biochemistry from University of Illinois, Urbana-Champaign, and Bachelor’s degree in Biochemistry from Moscow State University, Russia.

Apply Now